In the present study, we for the first time demonstrated that silencing LRIG2 could decrease the protein levels of AKT phosphorylation and inhibit the proliferation of OS cells, and downregulation of LRIG2 also inhibited OS tumor formation and growth in cell experimental subcutaneous xenograft tumor model in nude mice. This evidence concerns the gene LRIG2 and neoplasm.